Halle M, Berg A, Keul J
Lehrstuhl und Abteilung Rehabilitative und Präventive Sportmedizin, Medizinische Universitätsklinik Freiburg, Bundesrepublik Deutschland.
Wien Klin Wochenschr. 1997;109 Suppl 2:29-32.
Prospective epidemiological studies have proven a close link between the improvement of the lipoprotein profile and reduction of coronary heart mortality in coronary heart disease (CHD) patients. Both, regular physical activity and pharmacological intervention are capable of improving the lipoprotein profile and may independently reduce coronary stenoses and cardiac events in CHD patients. Because of the multifactorial genesis of atherosclerosis, regular physical activity is of major importance for cardiac rehabilitation and improvements of other risk factors besides the lipoprotein profile e.g. rheology, hypercoagulability, hypertension, peripheral insulin resistance and oxidative status may be expected. The combination of life-style changes e.g. physical activity, diet and smoking cessation together with pharmacological intervention, if risk factors remain high, seems to be the best therapy for patients with CHD. A sole pharmacological intervention seems to be insufficient.
前瞻性流行病学研究已证实,冠心病(CHD)患者脂蛋白谱的改善与冠心病死亡率的降低之间存在密切联系。规律的体育活动和药物干预都能够改善脂蛋白谱,并且可能独立降低CHD患者的冠状动脉狭窄和心脏事件。由于动脉粥样硬化的多因素成因,规律的体育活动对于心脏康复以及除脂蛋白谱之外的其他危险因素的改善至关重要,例如流变学、高凝状态、高血压、外周胰岛素抵抗和氧化状态。如果危险因素仍然很高,生活方式改变(如体育活动、饮食和戒烟)与药物干预相结合,似乎是CHD患者的最佳治疗方法。单纯的药物干预似乎是不够的。